Quick Answer
To get card processing for a GLP-1 telehealth clinic, apply with three documents ready: a licensed-prescriber attestation, a pharmacy sourcing letter and a written refund and recurring-billing policy.
Underwriters judge how you prescribe. Fierce Healthcare reported that Mochi Health requires a virtual visit before a GLP-1 prescription, while Ro sometimes relies on an asynchronous intake form. Either model can be documented. Once approved, clinics can accept credit card payments online or in person.
Key Points
- Apply with three documents ready: a licensed-prescriber attestation, a pharmacy sourcing letter, and a written refund and recurring-billing policy that meets the Restore Online Shoppers' Confidence Act.
- A Yale secret-shopper study published in JAMA found that 92% of 49 websites prescribed a GLP-1 and 69% mailed it, usually without a clinician verifying patient answers.
- Fact.MR reports that the FDA announced 30 warning letters to telehealth companies in March 2026 over false or misleading claims about compounded GLP-1 products.
Underwriters look at how a GLP-1 clinic prescribes, sources and bills before approving card processing.
Payment processors are now part of the GLP-1 enforcement story. On August 25, 2026, Medical Daily reported that Eli Lilly is pressing payment processors and social platforms as federal enforcement struggles to slow retatrutide sales. Your card account sits right in that line of fire.
The money keeps growing anyway. Fairfield Market Research projects the GLP-1 telehealth platform market to reach US$2.1199 billion by 2033, and it warns that a patient acquisition model built around misleading claims "creates operational and reputational exposure." Underwriters price that exposure first.
Below, I walk through why processors drop these clinics, why specialists still hold reserves, and the three documents that answer an underwriter before the questions start.
GLP-1 telehealth payment processing starts with questions Ophelia Johnson raised from the pharma manufacturer's side on the Relentless Health Value podcast in 2026: who ships the medication, who pays for shipping, and who pays the credit card fees? Processors price that shape, not the drug name.
A 2025 study of a German direct-to-consumer platform shows what a documented flow looks like in practice. Patients completed an online intake questionnaire, uploaded a photo and ID, and had their answers reviewed by a qualified physician, with medication shipped from an affiliated online pharmacy within 48 hours. In that 2025 study, after 50 days, 85.6% of its 966 patients reported losing more than 2 kg.
Every one of those steps can be written down. An underwriter can read it, and that is where your application starts.
Why do processors drop GLP-1 telehealth clinics?
Processors drop GLP-1 telehealth clinics because they price the category's prescribing, sourcing and refund risk, not your individual practice, so a careful clinic inherits the industry's worst cases.
Before you apply anywhere, ask three questions about your own operation:
- Can you show that a licensed clinician reviewed every prescription?
- Can you name the pharmacy that fills each order and how it ships?
- Can a patient cancel, and get a refund, without a fight?
Square gave a cash-pay Indiana practice a 30-day termination notice because it offered compounded medications. That practice had a physical office, a nurse practitioner working with a collaborative physician, and only in-state telehealth patients. The common assumption is that a license and a storefront protect you. They did not.
The category record explains why. A Yale secret-shopper study published in JAMA found that 92% of 49 websites prescribed a GLP-1 and 69% mailed it, usually without a clinician verifying what the patient reported. KFF Health News described a patient whose telehealth instructions called for a dose "nearly nine times the amount patients are typically told to take for their first dose." Compounding also rests on shifting ground: in one founder's account, the FDA removed semaglutide from the shortage list in February 2025, and that listing was the legal basis for bulk compounding.
Speed is the awkward trade-off. Fast approval sells to patients. Yet the Yale team flagged sites that approved a Monday evening request and delivered by Tuesday. I would rather give up a little conversion than look like those sites to an underwriter.
Our team's underwriting view, stated for another high-risk segment, is that a processor isn't really pricing the product label; it prices the shape of the business and how each element is controlled. An analysis of 5 sources for this article points to a question worth asking any processor: has it already boarded telehealth clinics that ship from a partner pharmacy and bill monthly? Clinics that document all three fit high-risk credit card processing programs built for that shape, and the first document an underwriter reaches for is the prescriber attestation.
What is a card underwriter actually checking in a GLP-1 clinic's file?
A card underwriter reading a GLP-1 clinic's application sees a website, a business entity and a product. Behind those sits the category's public record, and we went looking for what it says.
We started with prescribing. A Yale research team built the profile of a 27-year-old man who qualified for a GLP-1, and a secret shopper used it on 49 websites. In most cases he got a prescription without talking to a clinician who checked his answers. Some Monday evening requests were approved shortly after and delivered by Tuesday or Wednesday, said first author Ashwin Chetty.
Reshma Ramachandran, the study's senior author, said telehealth "can't just be a pay-to-prescribe sort of platform. It needs to be a pay-for-appropriate-treatment platform." Florida guidance, as summarized by GLP-1 program builder MDLaunchr, says prescribing solely from an electronic questionnaire is insufficient. Yet Marc-Andre Cornier, immediate past president of The Obesity Society, told KFF Health News that no government agency or medical society has written criteria for judging which providers treat patients appropriately. Without a shared standard, a licensed-prescriber attestation lets the clinic show its own.
The second question is where the drug comes from. Beyond the FDA's March 2026 warning letters, KFF Health News reported that compounded ingredients are commonly sourced from overseas suppliers. U.S. News & World Report's first GLP-1 telehealth ratings, published Aug. 12, 2026, left out every company selling only compounded versions, which its managing editor of health, Gretel Schueller, said are not reviewed by the FDA "for safety or quality, which can introduce contamination or dosing errors."
"Durable providers must show licensed review and safe prescribing. Pharmacy transparency and follow-up keep patients connected after the first dose."
Shambhu Nath Jha, Sr. Consultant, Fact.MR, 2026
A pharmacy sourcing letter answers that question by naming the pharmacy, its type and how medication reaches the patient.
Paperwork has limits, though. In September 2025, a small cash-pay Indiana medical office posted on Reddit that its mainstream processor had given it 30 days' notice over compounded medications and would, at minimum, stop letting it send payment links. The office had a physical location, a nurse practitioner working with a collaborative physician, only in-state telehealth patients and a 503A pharmacy shipping each order under the patient's name. "I guess we're considered 'high-risk' but I'm not sure how," the poster wrote. One office cannot speak for every processor, though its case suggests a general-purpose processor may react to the product before looking at the practice. One commenter said some providers "will require upfront KYB + pharmacy agreements." Most other replies were sales pitches.
The third document covers money that moves after the first charge. In a study of 53,590 patients in WeightWatchers' telehealth clinic, mean treatment lasted 5.3 months, so cancellation terms will see real use. The Restore Online Shoppers' Confidence Act requires online plans that bill automatically to disclose all material terms before taking billing details, get express informed consent before charging, and provide "simple mechanisms for a consumer to stop recurring charges."
Delivery brings its own arguments. An anonymous clinic owner who reported treating 1,000 to 5,000 patients a week wrote of being "pretty much over the 'ice packs arrived thawed, give me something free' charade." A refund policy written in advance shows the patient the rule for warm shipments before the first payment and gives the clinic a written answer if a dispute follows.
| What the record documents | The document that answers it | What it should state |
|---|---|---|
| Prescriptions issued without a clinician checking the patient's information | Licensed-prescriber attestation | Each prescriber, their license states, and how patients are evaluated |
| Compounded drugs from sources the FDA has not reviewed | Pharmacy sourcing letter | Pharmacy name, type (503A, 503B or specialty) and how medication ships |
| Recurring charges for a treatment many patients stop, plus delivery disputes | Refund and cancellation policy | Material terms, consent, a simple way to cancel, and the rule for warm deliveries |
The three documents line up with failures the public record already describes. MDLaunchr lists what operators may hand over during underwriting, including the clinical model, product descriptions, fulfillment information, and refund and recurring-billing terms. Each document covers part of that list with the clinic's own evidence, so an underwriter can judge this clinic instead of the category's worst cases. We approve high-risk and subscription businesses, so we have a stake in that argument. None of our sources measured how much faster a complete file gets approved.
- Build the prescriber attestation around evaluation: name each prescriber and the states where each is licensed, and state whether every patient gets clinician review beyond an online questionnaire.
- Ask your pharmacy for a letter giving its name, its type (503A, 503B or specialty) and how it ships, and ask where its active ingredients come from.
- Before applying, review every claim your site makes about compounded products; the FDA's March 2026 letters targeted false or misleading claims.
- Put ROSCA's three requirements on your checkout page, and state in writing what happens when a cold shipment arrives warm.
- If your processor restricts payment links, ask any replacement whether it boards compounded medication and link-based billing before you move.
How we checked this
We used a university summary of a peer-reviewed secret-shopper study, a peer-reviewed study of one telehealth program, KFF Health News reporting, a trade report on the U.S. News ratings, a market research report, a launch guide from a telehealth infrastructure company, the text of ROSCA, and two Reddit threads. None of the figures here come from SeamlessChex data. Limitations:
- The Yale summary gives the JAMA publication date as July 6 with no year.
- The retention study covers one program, and most of its authors work for that program's owner.
- The Reddit posts are unverified, and several commenters were selling services.
- MDLaunchr and Fact.MR sell services and reports to this market.
We process payments for high-risk merchants. Still unknown: how often processors drop documented clinics, and whether a complete file shortens approval.
- Yale School of Medicine, secret-shopper study on GLP-1 prescriptions, date not given.
- KFF Health News, report on GLP-1 telehealth oversight, June 1, 2026.
- Fact.MR, GLP-1 telehealth platforms market report, July 27, 2026.
- Telehealth.org, report on the U.S. News GLP-1 platform ratings, Aug. 24, 2026.
- MDLaunchr, guide to launching a GLP-1 telehealth program, Oct. 28, 2026.
- Ard et al., Obesity, WW Clinic telehealth outcomes study, Oct. 30, 2024.
- Legal Information Institute, 15 U.S. Code 8403 text, retrieved Nov. 11, 2026.
- Reddit r/PaymentProcessing, Indiana practice thread on telehealth processing, Sept. 24, 2025.
- Reddit r/Semaglutide, online weight loss clinic owner thread, March 14, 2025.
Why do specialist processors still set reserves and tight terms?
Specialist processors will approve GLP-1 clinics, but they are pricing recurring card charges for a medical product many patients stop within months, so reserves and billing conditions follow.
The subscription model is both the draw and the exposure. Cash-pay subscription is projected to be the largest GLP-1 telehealth revenue model in 2026, at 31.8%, because monthly billing gives platforms predictable revenue and patients skip prior authorization. Predictable for the clinic is not the same as predictable for the acquirer.
Patient persistence explains the gap. A 2024 study of a WeightWatchers Clinic telehealth cohort found a mean treatment duration of 5.3 months, with retention at 6 months of 63%. A 2025 study of a direct-to-consumer platform found that 88.9% of patients were new to GLP-1 therapy and 39.8% reported adverse events, mainly gastrointestinal.
Put those together. First-time patients feel side effects. Some stop. A renewal that charges a patient who has already quit is exactly where a chargeback begins.
Our underwriting team's read is that a processor prices delayed physical fulfillment as its own element of risk, separate from the product label. A GLP-1 order ships after payment, so a stalled package and an unwanted renewal can hit the same account in the same month. That is why a clinic comparing merchant payment processing solutions should expect questions about cancellation before anyone talks about rate, and the first of those questions is who signed off on the prescription.
What documents get a GLP-1 telehealth clinic approved faster?
A fast application carries three documents (a licensed-prescriber attestation, a pharmacy sourcing letter and a written refund policy) from an established business already processing $25,000 or more a month.
Underwriters will also want the basics: entity and ownership details, website disclosures, product descriptions and fulfillment information. A white-label telehealth vendor's launch guide lists exactly those items, plus refund and recurring-billing terms and the clinical model. The three documents below are where most clinics are thin, so I would build them before the first call with any processor.
| Document | The underwriter's question | What to include |
|---|---|---|
| Licensed-prescriber attestation | Who decides that a patient gets medication? | Prescriber names and licenses for every launch state, how intake is verified by a clinician, screening and contraindication criteria, starting dose and titration protocol, follow-up cadence |
| Pharmacy sourcing letter | Where does the drug come from, and who ships it? | Pharmacy name and type, its licensure, who ships to the patient, tracking and temperature handling |
| Refund and recurring-billing policy | What happens when a patient stops or a package stalls? | Plain subscription terms, consent before the first charge, a simple way to cancel, refund rules for shipping problems and medical stops |
The attestation matters most. U.S. News & World Report's first GLP-1 telehealth ratings weighted clinical support at 25% and screening rigor at 20% of the score, and left out every compounded-only seller. Underwriters read the same signals. A form-only approval path is a weak answer.
The billing policy has a legal floor. Under the Restore Online Shoppers' Confidence Act, a recurring plan needs clear disclosure of material terms, express informed consent before charging and a simple way to stop. Write to that standard.
Two side notes. One telehealth ad agency says LegitScript certification takes 4-8 weeks at best and is required to run Google Ads, so start it early. And if a prior processor already terminated you, read up on TMF/MATCH list merchant account approval before you apply. The evidence I have does not put a number on how much faster a complete file gets approved. What it shows is which gaps stall one.
What should a GLP-1 clinic do before applying for card processing?
Assemble the prescriber attestation, pharmacy sourcing letter and refund policy first, then apply to a processor that already underwrites telehealth, so your file answers the underwriter's questions on day one.
The paper trail works clinically, too. A 2024 study of 53,590 adults in the WeightWatchers Clinic program found average weight loss of 19.4% at 12 months, with intake running through an online qualification quiz, weight verification and a virtual visit with a board-certified clinician. That is a process an underwriter can read.
I expect documented oversight to matter more than prescribing speed over the next year or two. Speed sells in an ad. In an underwriting file, it raises questions.
SeamlessChex sets up credit card processing for clinics that take payments online or in person, with ACH as a second rail. Start with the pharmacy letter, because it needs a signature from someone outside your clinic.
Frequently Asked Questions
What else do clinic owners ask about GLP-1 telehealth payment processing?
Most follow-up questions cover regulatory pressure, market size, pharmacy documentation, subscription cancellation terms and onboarding speed, and each answer comes back to what a clinic can prove on paper.
Is regulatory pressure on GLP-1 telehealth increasing?
Yes. Fact.MR reports that the FDA announced 30 warning letters to telehealth companies in March 2026 over false or misleading claims about compounded GLP-1 products. The firm expects promotion review and pharmacy sourcing to become tests for choosing a provider. Underwriters read the same headlines.
How large is the GLP-1 telehealth market in 2026?
Fact.MR estimates the market at USD 763.8 million in 2026, forecast to reach USD 3,280.0 million by 2036 at a 15.7% CAGR. A second research firm projects the same growth rate through 2033. In my view, that growth is exactly why processors want documentation before volume.
What is a pharmacy sourcing letter?
A pharmacy sourcing letter is a signed statement from the pharmacy that fills your prescriptions, describing where the medication comes from and how it reaches patients. Fact.MR expects patients and partners to favor platforms that explain pharmacy routing, refills and sourcing before treatment starts.
Do GLP-1 subscriptions need written cancellation terms?
They do. Market research on the sector notes that subscription revenue depends on ongoing value and transparent cancellation terms. A recurring billing policy spells out the charge date, the amount and how a patient stops it.
How quickly can SeamlessChex onboard a GLP-1 clinic?
SeamlessChex offers same-day onboarding and no contracts for established clinics that meet its monthly volume minimum. Clinics can accept credit card payments online or in person, with ACH available as a second rail. Reach the team through the SeamlessChex contact page with your three documents ready.
Written by
Lily Flanigan
Operations Manager, SeamlessChex
Lily Flanigan is Operations Manager at SeamlessChex, a credit card processing and fintech payments platform recognized on the Inc. 5000, where she focuses on operations and process optimization.
Connect on LinkedInSeamlessChex works with established businesses processing a minimum of $25,000 per month.